FreMon Scientific has entered into a Sponsored Validation Study Agreement with the MedStar Georgetown University Hospital Cell Therapy Manufacturing Facility.
This collaboration will validate the performance of ZipThaw for off-label use in cell and gene therapy — a major milestone toward expanding its role in advanced therapeutic applications.



